We describe a novel cytokine receptor named GP130 Like receptor, or GPL, that displays similarities with the interleukin-6 and interleukin-12 family of signaling receptors. Four different isoforms diverging in their carboxyl terminus were isolated, corresponding to proteins encompassing 560, 610, 626, and 745 amino acids. Sequences included a signal peptide of 32 amino acids, followed by a cytokine binding domain containing four conserved cysteines, a WSDWS motif, and a region consisting of three fibronectin type III domain repeats. No immunoglobulin-like module was identified in the GPL sequences. The intracellular part of longer isoforms contained a proline-rich region defining a box1 motif for interaction with the Janus kinases. The Gpl gene is organized in 15 exons and is located on 5q11.2 in tandem with the gp130 gene. Both genes were only separated by 24 kilobases, with opposite transcriptional orientations. The GPL receptor displayed a 28% identity with gp130. Specific GPL transcripts were observed in tissues involved in reproduction. Transcripts were also found in blood cells and in bone marrow, revealing expression of GPL in all of the myelomonocytic lineage, from hematopoietic stem cells to activated dendritic cells. In monocytes and dendritic cells, expression of GPL was strongly up-regulated by interferon-␥, indicating a possible involvement of GPL in Th1-type immune responses. The molecular basis of cell signaling mediated by GPL was studied using chimeric receptors where external portions of ␣ or ␤ interleukin-5 receptor subunits were fused to the internal portion of GPL or of related receptors. Results indicated that association of GPL to the intracellular portions of gp130, or LIF receptor, allowed the signaling cascade.
Cytokine receptors associate to define functional multimeric membrane receptor complexes, which are recognized and activated by their cognate ligand(s) (1) . Usually two large size transmembrane subunits are required to allow dimerization and downstream signaling events in response to a cytokine (2) . Some ligands, such as interleukin (IL) 1 -2 for example, also implicate a third additional component to increase their affinity to the membrane (3) .
Numerous receptor components are shared to elaborate different high-affinity receptor complexes. The shared use of receptor subunits was retained to classify and analyze the biological functions of cytokines. On the basis of this notion, IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 were gathered to define the cytokine family sharing the "␥ chain" in the formation of their functional receptors (3, 4) . Similarly, additional gatherings of cytokines were defined based on their common use of ␤c (IL-3, IL-5, and granulocyte/macrophage-colony stimulating factor) (5), IL-4R (IL-4 and IL-13) (6), IL-7R (IL-7 and thymic stromalderived lymphopoietin) (7) or IL-12R␤1 (IL-12 and IL-23) (8 -10) .
The latest family of cytokines is known as the IL-6 family of cytokines and encompasses, besides IL-6, the viral IL-6, IL-11, leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF), cardiotrophin-1 and cardiotrophin-like cytokine. All share the common gp130 signaling receptor in their multimeric receptors (11) . Depending on the identity of the activating ligand, gp130 can either homodimerize in the presence of IL-6 or IL-11 (12, 13) or associate with a related type I cytokine receptor, LIF receptor (LIFR) (14) , when recruited by LIF, OSM, CNTF, cardiotrophin-1, or cardiotrophin-like cytokine (15) (16) (17) (18) (19) . OSM can also activate a specific receptor implicating OSM receptor (OSMR) (20) . For some of these receptor complexes, a third additional ␣ component leading to an increased specificity and affinity is required to generate fully functional receptors. This is the case for IL-6 receptor ␣, IL-11 receptor ␣, and CNTF receptor ␣ (21, 22) .
In the present report, we describe a novel cytokine receptor displaying similarities with gp130 signaling receptor we previously presented in a meeting (23) . A related receptor was described recently, but the reported sequence was incomplete, thus preventing expression of the corresponding protein (24) . This receptor we named GPL, for GP130 Like receptor, which displayed some homologies with LIFR, OSMR, and the IL-12 receptor family members. Interestingly, analysis in the inver-tebrates of the cytokine receptor, Dome, indicates that GPL is the closest equivalent in the human genome. In addition, we show that GPL can associate to the intracellular parts of gp130 or of LIFR to generate a functional response.
MATERIALS AND METHODS
Cells and Reagents-The cell lines used in the study were from American Type Culture Collection (Rockville, MD) and were grown routinely in RPMI 1640 supplemented with 10% fetal calf serum and appropriate cytokine when required. Human T-cell clones were kindly provided by Dr. Jean-Claude Lecron from Poitiers University. Mononuclear cells and cell subsets were isolated from bone marrow using immunomagnetic cell sorting (AutoMacs cell sorter, Miltenyi Biotec, Bergisch Gladbach, Germany) and flow cytometry cell sorting (Becton Dickinson, San Jose, CA). Reanalysis of the sorted populations indicated a purity Ͼ95%. Dendritic cell cultures were carried out as described previously in detail (25, 26) . Briefly, dendritic cells were generated from adherent monocytes and cultured with granulocyte/ macrophage-colony stimulating factor and IL-4 before activation with IFN-␥ (10 ng/ml), LPS (100 ng/ml), IL-1␤ (10 ng/ml), CD40 ligand (CD40L) (1 g/ml), or tumor necrosis factor (TNF)-␣ (25 ng/ml). CD34ϩ cells were isolated from mobilized peripheral blood and cultured with a cytokine mix as described previously to generate dendritic cells. The anti-GPL polyclonal antibody was raised by immunizing rabbits with a 15-mer peptide (CSFFLPRITIPDNYT) chosen in the AB loop of the receptor. The immunoglobulin fraction was purified by caprilic acid precipitation.
Gene Analysis-The amino acid sequence of human gp130 was used to screen the public High-Throughput Genome Sequence database using BLAST (27, 28) . Overlapping fragments were ordered, and the resulting gene candidate was analyzed by GENSCAN (29) . The signal peptide was identified by SignalP (30) , and the transmembrane domain was identified by TMHMM (31) by using the bioweb.pasteur.fr server. Determination of the N-glycosylation site occupation was carried out using NetNGlyc 1.0 Prediction site 2 (32) . The sequence alignment of the most similar receptors was made using ClustalW (33) and manually refined. The alignment of the cytokine binding domain (CBD) and the three fibronectin III (FnIII) domains of each sequence was used to draw a phylogenetic tree using the Phylip package (34) . A distance matrix was built with the program PROTDIST (35) and used to build the tree using NEIGHBOR (36) with the UPGMA (Unweighted Pair Group Method with Arithmetic mean) algorithm (37) . The graphical output of the tree was obtained with TreeView 1.6.5 3 (38) . Sequence and structure of Dome was analyzed using Motifscan 4 (39), T-coffee (40) , and Tmpred. 5 The identity and similarity rates were computed using GeneDoc (41) .
Cloning and Expression of GPL-Total RNA was isolated from the U937 myelomonocytic and the GO-G-UVM glioblastoma cell lines with TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Complementary DNA was synthesized from 2 g of RNA by random hexamer priming using SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA). In accordance with the in silico screening and to exclude any genomic amplification, PCR primers located in two different exons were designed (forward primer gttttgggcatcaaacgaat and reverse primer ggctccagtcactccagaac). The amplified PCR fragments were cloned into pGEM-T vector (Promega, Madison, WI), and independent clones were sequenced (Beckman Coulter Inc., Fullerton, CA). The obtained sequence was used to design primers for both 5Ј-RACE and 3Ј-RACE. RACE was performed with SMART RACE cDNA Amplification kit (Clontech, Palo Alto, CA) according to the manufacturer's instructions. Both strands of 5Ј-and 3Ј-RACE amplification were cloned into pGEM-T vector and were then sequenced (Beckman Coulter Inc.). To obtain a GPL full-length cDNA, another pair of FIG. 1. cDNA sequences of different GPL isoforms. A, nucleotide sequence and predicted amino acid sequence for the longest form of GPL (GPL 745 ). Signal peptide, WSXWS motif, transmembrane region, and the Jak fixation box (box 1) are surrounded by light gray, medium gray, dark gray, and black boxes, respectively. The four conserved cysteines and the three intracellular tyrosines are framed by circles and squares, respectively. ‫,ء‬ the position of N-glycosylation sites. B, predicted amino acid sequences of three shorter isoforms of GPL (GPL 560 , GPL 610 , and GPL 626 ) diverging after the transmembrane segment.
primers was designed, and amplification was made using a proofreading Taq polymerase (Invitrogen). The full-length cDNA was cloned into the mammalian expression vector pcDNA3.1 (Invitrogen). COS-7 cells were transfected by the DEAE-dextran method or by using the Exgen reagent (Euromedex, Mundolsheim, France). After a 72-h culture period, expression and function of recombinant proteins were studied.
Detection of GPL mRNA by RT-PCR and Quantitative PCR-Total RNA was isolated from the indicated sources using TRIzol reagent (Invitrogen). cDNAs were synthesized from 2 g of RNA by random hexamer priming using SuperScript II reverse transcriptase (Invitrogen). cDNA was subsequently amplified by 35 cycles of PCR using the following primers: forward gttttgggcatcaaacgaat and reverse ggctccagtcactccagaac for GPL, forward gaaggtgaaggtcggagtc and reverse gaagatggtgatgggatttc for GAPDH. The primers for GPL were designed in exons 5 and 6 to prevent any genomic DNA amplification. PCR products were analyzed by agarose gel electrophoresis. Quantitative PCR was performed and analyzed on a capillary real-time thermocycler (LightCycler, Roche Diagnostics, Mannheim, Germany). Amplification was done in the presence of SYBR Green I as follows: in 10 l of final volume, cDNA was mixed with LightCycler-Fastart DNA Master SYBR Green (Roche Diagnostics), 5 nM forward primer and 5 nM reverse primer, and 4 mM MgCl 2 . Glass capillaries were placed into the LightCycler rotor, and the following run protocol was used: a denaturing step at 95°C for 10 min, then an amplification and quantification program repeated for 40 cycles: 95°C for 15 s, 55°C for 11 s, and 72°C for 22 s. At the end of elongation at each cycle, SYBR Green I fluorescence was measured. Data analysis was essentially performed as indicated by Roche using "Fit Point Method" in the LightCycler software 3.3 (Roche Diagnostics). Relative quantification was made against serial dilution of GAPDH cDNA used as a housekeeping gene.
Northern Blot Analysis-Northern blots were performed using a cDNA probe encoding for the extracellular portion of GPL or a GAPDH cDNA probe. Total RNAs were extracted with TRIzol reagent (Invitrogen) according to the manufacturer's instructions. Hybridizations were carried out in the presence of Quikhyb solution (Stratagene, La Jolla, CA) as described by the supplier.
Construction of IL-5 Receptor/GPL Chimera-pSVLhuIL-5R␣/ hugp130 (␣130), pSVLhuIL-5R␤/hugp130 (␤130), and pSVLhuIL-5R␤/ huLIFR (␤LR) plasmids encoding the external portions of IL-5 ␣ or ␤ receptors fused to the internal parts of gp130 or LIFR were kindly provided by Dr. P. Heinrich (Aachen, Germany) (42) . The cDNA encoding the gp130 transmembrane and cytoplasmic part was exchanged with the corresponding sequence of the GPL (pSVLhuIL-5R␣/huGPL (␣GPL), pSVLhuIL-5R␤/huGPL (␤GPL)) using PCR with oligonucleotides CGGAATTCAAGACATTGTCATTCAG (sense) and CGGGATC-CAAGCTTTGTTTAGACTTCTCC (antisense). Recombinant plasmids were sequenced (Beckman Coulter Inc.). Underlined letters indicate EcoRI and BamHI restriction enzyme sites used for ligation into the pSVL vectors encoding the extracellular domains of IL-5R␤ or of IL-5R␣.
Western Blot Analysis-Cells were lysed in 10 mM Tris-HCl, pH 7.6, 5 mM EDTA, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM sodium fluoride, 1 mM sodium orthovanadate, proteinase inhibitors (1 g/ml pepstatin, 2 g/ml leupeptin, 5 g/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride), and 1% DOC or Brij 96, depending on the experiments. After a centrifugation step to remove cell debris, samples were submitted to SDS-PAGE and transferred onto an Immobilon membrane. The membranes were subsequently incubated overnight with 0.2 g/ml polyclonal anti-GPL antibody, an anti-phospho-STAT3 (Cell Signaling Technology, Beverly, MA), or an anti-STAT3 (Santa Cruz Biotechnology, Santa Cruz, CA) before being incubated with the appropriate secondary antibody labeled with peroxidase for 60 min. The reaction was visualized on an x-ray film using the ECL reagent (Amersham, Les Ullis, France) according to the manufacturer's instructions.
Endoglycosidase Treatment-5 ϫ 10 4 transfected COS-7 cells were lysed in 10 mM Tris-HCl, pH 7.6, 5 mM EDTA, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM sodium fluoride, 1 mM sodium orthovanadate, proteinase inhibitors (1 g/ml pepstatin, 2 g/ml leupeptin, 5 g/ml aprotinin, and 1 mM phenylmethylsulfonyl fluoride), and 1% Brij 96. Cell lysates were next treated with 25 units/ml of Nglycosidase-F (Roche, Mannheim, Germany) for 12 h at 37°C before GPL Western blot analysis.
Luciferase Reporter Gene Assay-COS-7 kidney cell transfections were carried out in 24-well culture plates using the Exgen transfection reagent. Cells were transfected with 4 g of plasmid DNA and 150 ng of SIEM-Luc reporter gene. This construct contains three consensus binding sites located upstream of a thymidine kinase minimal promoter (43) . Seventy-two h after transfection, cells were serum-starved overnight and then incubated with medium alone or with the indicated cytokine for the next 7 h. Cells were PBS washed, and 75 l of lysis buffer was added to the wells (0.1 M KHPO 4 , pH 7.8, 0.1% Triton X-100) for 20 min at 4°C. Extracts were then used to measure the luciferase activity using a Packard Topcount luminometer (Meriden, CT).
RESULTS
Identification of GPL Receptor-Gp130 cDNA sequence was used to screen the human genomic National Center for Biotechnology Information database, and a novel cytokine receptorencoding sequence was located on chromosome 5 in the vicinity of gp130 (23) . PCR primers located in two different putative exons were designed and used to identify cell lines expressing a corresponding mRNA. Encoding cDNAs were independently isolated from the U937 myelomonocytic and the GO-G-UVM glioblastoma cell lines by RACE PCR. According to its homology to gp130, this novel cytokine receptor was named GPL. Four cDNA clones diverging in their carboxyl terminus were isolated (Fig. 1) . The sequences included a potential hydrophobic signal peptide of 33 amino acids, followed by a CBD containing four conserved cysteine residues in fixed positions, a WSDWS motif, and then a region consisting of three FnIII domain repeats (44, 45) . GPL receptor contained a stretch of 28 hydrophobic amino acids aligning with the transmembrane domain of neighboring cytokine receptors. In the four isolated sequences, the predicted carboxyl-terminal sequences were identical throughout the transmembrane domain until Asn 560 . Beyond this point, cDNAs predict proteins with differing cytoplasmic portions, leading to a shorter receptor containing 560 residues and corresponding to the first 13 exons of the gene (Fig. 2B) . The three remaining forms displayed alternative 3Ј ends in the fifteenth exon and led to 610, 626, and 745 amino acid proteins. A truncated sequence encoding for a soluble form of receptor containing 509 amino acids was also recorded before by another group as CRL3 (access number AF106913-1).
Thirteen N-glycosylation sites were predicted as potentially occupied in GPL 745 according to the NetNglyc 1.0 prediction. This was confirmed by an enzymatic treatment of the protein as presented below in the report (Fig. 9C) . Examination of the cytoplasmic domain of GPL 610 , GPL 626 , and GPL 745 isoforms shows an intracellular motif surrounding Pro 568 , Pro 571 , and Pro 573 that defined a membrane-proximal box 1 motif, important for its association with the Janus protein kinase (Jak) (46) .
Gpl and gp130 genes were both localized on human 5q11.2 and were only distant from each other by 24 kilobases, with opposite transcriptional orientations ( Fig. 2A) . The computerpredicted exon organization using GENSCAN (29) revealed that the gpl gene contained 15 exons (Fig. 2B) . The first 12 exons encode the extracellular region. The transmembrane region is encoded by exon 13. The last 2 exons contain the cytoplasmic domain of the receptor including the box 1 motif required to associate the Jaks. The general intron/exon organization of the gpl gene is very similar to that of gp130 (47) , suggesting a gene duplication event.
Computer analysis revealed that GPL protein displayed consistent homologies with IL-6 and IL-12 cytokine families of receptors as well as with the granulocyte-colony stimulating factor receptor (Figs. 3 and 4) (8, 9, 11, 14, 48, 49) . The nearest identified human protein was gp130, displaying a 28% identity rate with the GPL receptor (Figs. 3 and 4A ). This was further sustained by building an evolutionary dendrogram, indicating that GPL and gp130 were the closest neighbors (Fig. 4B) . Analysis of GPL module organization underlined some structural similarities between this receptor and the common ␤1 chain for IL-12/IL-23 as well as with the IL-27R (Fig. 4C) . Similarly to that reported for the IL-12R␤1 and IL-27R chains, no conventional STAT binding box could be identified in the GPL sequence (Figs. 1 and 4C) (8, 49) .
The Jak/STAT pathway in invertebrates is less redundant than in mammals, offering a simpler model for the functional analyses. In the Drosophila genome, only two cytokine receptors localized in tandem, dome and cg14225, have been reported (50 -52) . Interestingly, the closest human ortholog to dome is gpl (Fig. 5) . The CBD and the FnIII domain of Dome and GPL displayed an average similarity level of 29.7%. The structural gene organization, the homology and similarity, as well as the absence of an additional large-size cytokine receptor in the Drosophila genome suggest a common ancestral origin of gpl and dome. Mouse GPL sequence identified from genomic databases (AF486621-1) was also compared and displayed a respective homology of 72 and 28.5% with the human and drosophila receptors, respectively.
GPL Tissue Distribution-Preliminary information on GPL distribution was obtained by RT-PCR analyses carried out in a number of cell lines to identify a mRNA source for GPL cloning (Fig. 6A) . Results showed expression of GPL in GO-G-UVM and U87MG glial-derived cell lines, in the A375 melanoma cell line, and in U937 and THP1 myelomonocytic cell lines. Neuroblastoma, osteosarcoma, choriocarcinoma, and hepatoma cell lines that were tested failed to give any detectable signal. Similarly, no transcript was found in cells of erythroid and lymphoid origins.
Northern blot analyses were performed to further characterize the size of GPL transcripts (Fig. 6B) . Experiments carried out in U937, A375, and GO-G-UVM cell lines revealed the presence of two major transcripts, 8.5 and 2.8 kb, respectively, in size. This is in agreement with the isolation of different forms of GPL encoding cDNAs.
Tissue distribution was analyzed by real-time quantitative RT-PCR using a panel of different human tissue poly(A)ϩ mRNA and PCR primers unable to detect genomic gpl DNA (Fig. 7A) . Specific GPL transcripts were observed for tissues involved in reproduction, including testis, ovary, prostate, and placenta. Of note, the highest GPL expression was detected in testis. Several tissues important for immune responses also expressed high levels of GPL mRNA, for instance spleen, thymus, and blood leukocytes. Expression of GPL in lung might be attributable to expression in parenchyma or in infiltrating alveolar macrophages, and these possibilities remain to be further tested.
Distribution of GPL in subsets of blood and bone marrow cells was further studied using purified sorted cell populations (Fig. 7B ). Analyses were carried out by real-time PCR using similar conditions. Whereas the B, T, natural killer, cells and erythroid progenitor cells consistently failed to express the GPL receptor, a readily detectable signal was observed in CD11b-or CD14-positive cell populations. The present results indicated a preferential expression of GPL receptor in cells of myelomonocytic origin, corroborating the results obtained with the U937 and THP1 monocytic leukemia cell lines. Similar results were found in two additional experiments using bone marrow and blood samples coming from different donors (data not shown). Expression of GPL was also determined in hematopoietic progenitor and stem cells (Fig. 7B) . Hematopoietic progenitors were defined by expression of the CD34 antigen on the cell surface. Hematopoietic stem cells, displaying a longterm repopulating potential, were isolated for their membrane expression of the CD133 marker (53, 54) . A weak but consistent expression was detected in CD34 progenitor cells and was enhanced in more primitive CD133-positive hematopoietic stem cells.
Dendritic cells, which are powerful antigen-presenting cells for the immune response, were generated starting from either monocytes or CD34-positive bone marrow cells by growing them in the presence of the appropriate cytokines (26) . After culture, RNAs were extracted, and the presence of GPL transcripts was searched by RT-PCR using PCR. Both dendritic cells originating from bone marrow and monocytes were found to express consistent amounts of GPL transcripts (Fig. 7C) .
Regulation of GPL Expression by IFN-␥ in Monocytes and
Dendritic Cells-Dendritic cells generated from adult bone marrow and purified peripheral monocytes were grown in the presence of the indicated activators (Fig. 8) . After a respective contact time of 6 and 15 h with the indicated cytokines, total RNAs were isolated, and the induction of GPL transcripts were analyzed. IFN-␥ treatment induced a very strong increase of gpl gene transcription in both monocytes and dendritic cells, whereas LPS remained inefficient or even down-regulated GPL-induced expression. In contrast, TNF-␣ or a phorbol ester failed to up-regulate GPL expression. Similarly to IFN-␥, an up-regulation of GPL was observed, but to a lesser extent, by adding IL-1␣ and CD40L to dendritic cells. Because only Th1 and natural killer cells secrete IFN-␥, the obtained results suggest that cooperation between dendritic cells and these two latest populations could induce an optimal expression of GPL during cellular immune responses.
Detection of GPL Protein-A 15-mer peptide corresponding
FIG. 4. Comparison of GPL protein to related cytokine receptors.
A, identity rates of cytokine receptors homologous to GPL: GPL, gp130, OSMR, LIFR, IL-12R␤1, IL-12R␤2, granulocyte-colony stimulating factor receptor (G-CSFR), and IL-27R identity rates are expressed in percentages. Calculations were done with a multiple sequence alignment involving the CBD and the three FnIII domains of each cytokine receptor built with ClustalW. For LIFR, the carboxyl-terminal CBD was used. B, phylogenetic tree built from the sequence alignment described under "Materials and Methods." C, schematic representation of GPL most-similar cytokine receptors. Each circle represents a module: gray, FnIII domains; white with one line, module containing the WSXWS motif in the CBD; white with two lines, module containing the four conserved cysteines in the CBD; black, Ig-like domain. In the intracellular part of the protein, box 1 and box 3 are represented by black and gray boxes, respectively. to the extracellular AB loop of the CBD of the receptor was used to immunize rabbits and generate the C15 antibody. GPL 560 short isoform was expressed in COS-7 cells, and Western blotting experiments were carried out using the C15 antibody (Fig.  9A) . Whereas the preimmune serum failed to recognize the receptor, a clear band corresponding to GPL and displaying an apparent molecular weight of M r 98,000 was detected when using the C15 antibody. The C15 antibody did not cross-react with the related LIFR, and GPL recognition was entirely abrogated when an excess of antigenic peptide was added to the membrane before staining. Addition of an irrelevant peptide in the assay did not affect the staining of the membrane observed in the presence of C15 antibody, demonstrating the specificity of the used C15 antibody (Fig. 9A) .
The GPL 560 , GPL 610 , GPL 626 , and GPL 745 isoforms were expressed in the COS-7 cell line, and Western blotting experiments were carried out using C15 antibody (Fig. 9B) . The respective apparent molecular weights of the expressed proteins GPL 560 , GPL 610 , GPL 626 , and GPL 745 were M r 98,000, 103,000, 105,000, and 120,000, respectively.
Deglycosylation experiments were carried out using N-glycosidase-F to remove the N-linked polysaccharides from the protein backbone. For each analyzed isoform, a shift of ϳ40,000 was observed in agreement with the predicted occupancy of 13 N-glycosylation sites using the NetNGlyc 1.0 Prediction site (Fig. 9C) .
Additional experiments were achieved to visualize the native form of GPL. The THP1 myelomonocytic cell line expressing GPL mRNA and the U266 lymphocytic cell line, lacking detectable GPL transcript, were analyzed for the expression of GPL by Western blotting (Fig. 9D) . Obtained results indicated a clear expression of the GPL protein in THP1 cells, confirming expression of its mRNA in this cell line. The apparent molecular weight of the protein was M r 105,000, suggesting a predominant detection of an intermediate GPL isoform in THP1 cells.
GPL Can Heterodimerize with gp130 or LIFR to Generate a Functional
Response-To investigate the molecular basis of cell signaling mediated by GPL, we analyzed the possibility for GPL to homodimerize or to associate with neighbor receptors, gp130 and LIFR. To carry out these experiments, chimera receptors were generated by fusing the external portions of ␣ or ␤ IL-5 receptor subunits to the internal part of the GPL 745 isoform. The COS-7 cell line, which failed to express any IL-5 receptor subunit, was used as a recipient cell line to express the chimera receptors (42) . ␣IL-5R/GPL (␣GPL) was expressed together with ␤IL-5R/GPL (␤GPL), ␤IL-5R/gp130 (␤gp130), or FIG. 6 . GPL RNA expression in human cell lines. A, PCR analysis of GPL in human cell lines. RNAs were prepared from human cell lines, and 2 g were reverse transcripted (RTϩ) or not (RTϪ). RT products were amplified using GAPDH primers as control or GPL primers chosen in exons 5 and 6, as indicated in "Materials and Methods." The GPL primers were designed in exons 5 and 6 to prevent any genomic GPL DNA amplification. B, Northern blot analysis of human GPL. RNAs were prepared from human cell lines WRL-68, U266, U937, A375, and GO-G-UVM separated on a 1% agarose gel, transferred to a nitrocellulose membrane, and hybridized with a GPL DNA probe (upper panel). Reprobing with GAPDH (lower panel) served as a loading control.
FIG. 7. Tissue distribution of GPL transcripts.
In A and B, GPL mRNA expression levels were given relative to the housekeeping gene mRNA, GAPDH. A, distribution of GPL mRNA in human tissues. B, GPL expression pattern in human blood cells. C, PCR analysis of GPL in monocytes and dendritic cells derived from monocytes or CD34-positive bone marrow cells.
␤IL-5R/LIFR (␤LIFR) and with SIEM-Luc reporter gene (Fig.  10A ). Seventy-two h after transfection, cells were activated with IL-5, with IL-2 as control, or untreated, and the transcriptional activity of the system was measured. A 2-to 5-fold increase of luciferase expression was induced by IL-5 when GPL was combined with gp130 or to LIFR, but no signal was observed when the intracellular portion of GPL was induced to form a homodimer.
In a second set of experiments, COS-7 cells were transfected with the same chimera receptors, and the tyrosine phosphorylation level of endogenous STAT3 signaling molecule was analyzed (Fig. 10B) . A clear induction of STAT3 tyrosine phosphorylation was detected when the intracellular portion of GPL was coexpressed together with gp130 or LIFR cytoplasmic parts and recruited by IL-5. This result reinforced the data obtained using the SIEM gene reporter assay and confirmed the possibility that GPL associates with gp130 or with LIFR to generate functional responses.
DISCUSSION
In the present study, we report the identification of a novel cytokine receptor named GPL that we previously described in the 2002 International Cytokine Meeting (23) . This receptor is structurally related to the receptors for the long-chain cytokines encompassing the IL-6/IL-12 type cytokines and granulocyte-colony stimulating factor (8 -11, 14, 20, 48, 49) . A recent study reported a partial sequence of a similar receptor (24) . But the absence of a large portion of the leader sequence did not allow expression of any corresponding protein, rendering its subsequent functional analysis difficult. Similarly, a computer screening predicted a soluble form of GPL receptor named CRL3 (AF106913-1). In our work, we present a revised cDNA sequence with a total of 39 additional nucleotide sequences in the 5Ј side, allowing the expression and the detection of four different GPL isoforms. The external part of the GPL receptor is made of a canonical CBD, followed by three FnIII domains (44, 45) . In contrast to that observed for related receptors, such as gp130, LIFR, OSMR, IL-12R␤2, or granulocyte-colony stimulating factor receptor, there was no evidence of an immunoglobulin-like (Ig-like) type domain on the amino-terminal side of GPL. The situation is very reminiscent of that reported before for the IL-12R␤1 and more recently for the IL-27R (Fig.  4C) (8, 49, 55) .
Site-directed mutagenesis, molecular modeling, and crystallography studies have shown that most of the long-chain cytokines interact with their receptor chains through three binding sites, numbered from I to III. Cytokines requiring a short coreceptor ␣ chain (IL-6, IL-11, IL-12, IL-23, IL-27, CNTF, and CLC) bind first to this subunit through a site I located in the CBD portion of the receptor (17, 19, (55) (56) (57) (58) (59) (60) . Then, the CBD of some large-size cytokine receptors (gp130, IL-12R␤1, and granulocyte-colony stimulating factor) interact with the cytokine(s) through site II (57, (61) (62) (63) (64) . Recruitment of an additional site of interaction (site III) located on the Ig-like domain of a second large-size receptor leads to oligomerization and signaling of the receptor complex (65) (66) (67) (68) (69) . Because no Ig-like domain is present in GPL, we can hypothesize that GPL should interact with its potential ligand(s) through a site II or a site I. GPL also likely implicates a neighbor receptor holding an Ig-like module to define the site III and to allow the dimerization process of large-size signaling subunits and subsequent signaling events.
Chimeric receptors based on the extracellular parts of IL-5R ␣-and ␤-chains fused to the internal portion of GPL, gp130, or LIFR were used to identify signaling cascades. Results show that a self-dimerization process of GPL led to no or to a marginal functional response, in contrast to that reported before (24) . Interestingly, GPL can contact and recruit LIFR or gp130 intracellular portions. This opens the possibility that GPL associates with the wild-type forms of these receptors or related receptors to generate functional complexes on the cell surface. This point is currently being investigated in the laboratory. Additionally, the involvement of a second receptor chain harboring an Ig-like module is very likely allowing the GPL-ligand to recognize it through a site III interaction motif.
Examination of the cytoplasmic domain of GPL shows the presence of a membrane-proximal box 1 motif (residues 568 -573) important for association with Jaks (46). This proline-rich region is present in three of four isolated GPL receptor isoforms. The one lacking a proline-rich region also lacked the box 1 motif and stops shortly after the transmembrane region. This might correspond to a non-signaling form of receptor as described previously in the cases of leptin and prolactin receptors, for example (70, 71) .
Dimerization processes of GPL allow the tyrosine phosphorylation of STAT3 and the recruitment of a SIEM-Luc reporter gene. Usually, activation of the STAT3 signaling molecule requires a canonical YXXQ box 3 motif in the receptor sequence behaving as a docking site for the signaling molecule, as described for gp130, LIFR, or OSMR (72) (73) (74) . Interestingly, this motif could not be identified in the isolated GPL cDNA sequences. Another possibility is a recruitment of STAT3 by gp130 or LIFR intracellular portions when associated with GPL (73) . This could also explain the almost absence of signal, when GPL is triggered as a homodimer receptor.
Genomic localization of gpl indicated its position on chromosome 5 in tandem with gp130. Both genes were only 24 kilobases apart and displayed a very similar intron/exon organization, suggesting that they likely arose from a gene duplication event. Interestingly this cytokine receptor cluster was very conserved during evolution, and a similar situation is observed in Drosophila. Only two related cytokine receptors could be found in the Drosophila genome. Dome receptor is a large-size signaling receptor and is located in the vicinity of cg14225, a short-type subunit. They both display homology levels with the IL-6 family of receptors and are thought to behave, in Drosophila, as the gp130/IL-6R complex. Interestingly, the CBDs and FNIII domains of GPL and Dome are 29.7% similar, suggesting that they share a common origin. Dome appears to be a unique large-size cytokine receptor present in the Drosophila genome (50, 51) . Dome and gpl are probably related to an ancestral receptor that gave rise to the entire family of cytokine receptors.
It is noteworthy to mention that Dome and its ligand, UPD, play important functions in Drosophila in embryonic segmentation and blood development (75) . The Dome pathway also maintains the niche for germ-line stem cells in the follicles and testis (52) . Interestingly, the highest expression of GPL in human was also detected in testis. GPL transcripts are also present in ovary, prostate, and placenta, suggesting a possible role of GPL in the biology of gonads and in mammalian reproduction.
Beside this, a strong expression of the receptor was evidenced during the different stages of the myelomonocytic lineage differentiation. GPL was present from early hematopoietic CD133ϩ stem cells to monocytes and mature dendritic cells. Additional expression of GPL in lung might be associated with the presence of alveolar macrophages in this tissue, but this remains to be further analyzed. Up to now, we failed to detect a GPL expression in lymphoid cells, but it is still possible that activation stages of B, natural killer, or T cells could play important roles for GPL expression in the immune cells. In line with this, we show that IFN-␥ is a major positive regulator of GPL expression in monocytes and dendritic cells. Interestingly, LPS by itself has no effect on GPL expression, and is even able to down-modulate GPL induction observed in the presence of IFN-␥. This regulation of receptor expression is similar to that reported recently for IL-12R␤1 and IL-23R (10) . Regulation of GPL expression suggests the possibility that IFN-␥ induces macrophages and dendritic cells to become sensitive to a GPL cognate ligand in the context of a Th1 immune response (76) . In the present study, we report the identification of the full-length sequence and protein expression of a novel cytokine receptor named GPL. Analysis of its structural modules revealed a lack of an Ig-like domain, suggesting that GPL would associate to a second signaling receptor owning an Ig-like domain to recruit a ligand through the appropriate binding sites. Chimera receptors show that both gp130 and LIFR intracellular portions can FIG. 10 . Induced heterodimerization of the cytoplasmic parts of GPL with gp130 or LIFR leads to STAT3 phosphorylation and activation. COS-7 cells were transfected with expression plasmids encoding the chimeric receptors pSVLhuIL-5R␣/hugp130 (␣130), pSVLhuIL-5R␤/hugp130 (␤130), pSVLhuIL-5R␤/huLIFR (␤LIFR), pSVLhuIL-5R␣/huGPL (␣GPL), or pSVLhuIL-5R␤/huGPL (␤GPL) as indicated along with reporter gene SIEM-Luc. A, 72 h after transfection, cells were stimulated for 7 h with IL-5 (50 ng/ml) (black), IL-2 (50 ng/ml) as irrelevant cytokine (dark gray), or untreated (light gray). The cellular extracts were prepared and used to directly measure luciferase activity. B, 48 h after transfection, cells were stimulated with or without IL-5 (50 ng/ml) for 10 min. After lysis in 2% SDS, lysates were subjected to immunoblot analysis with antibodies specific for activated STAT3 (STAT3-P). The blot were stripped and reprobed with an antibody recognizing both activated and nonactivated STAT3 proteins. WB, Western blot.
associate to GPL to recruit the signaling machinery. The exact nature of GPL cognate ligand(s) and the definitive identity of the GPL coreceptor remain to be identified. GPL tissue distribution and its similarity rate with the Dome Drosophila receptor also suggest that the GPL pathway might play important functions in mammalian reproduction as well as in the initial stages of the immune response.
